27.57
+3.58
+(14.90%)
As of 2:46:37 PM EST. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 5 | 3 | 5 | 5 |
| Avg. Estimate | 0.35 | 0.26 | 1.31 | 1.29 |
| Low Estimate | 0.32 | 0.2 | 1.2 | 1.12 |
| High Estimate | 0.38 | 0.31 | 1.52 | 1.46 |
| Year Ago EPS | 0.31 | 0.27 | 1.16 | 1.31 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 10 | 7 | 10 | 10 |
| Avg. Estimate | 1.27B | 1.23B | 4.92B | 5.23B |
| Low Estimate | 1.23B | 1.2B | 4.88B | 5.1B |
| High Estimate | 1.3B | 1.27B | 4.95B | 5.38B |
| Year Ago Sales | 1.12B | 1.15B | 4.3B | 4.92B |
| Sales Growth (year/est) | 12.98% | 6.92% | 14.41% | 6.31% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | 0.29 | 0.22 | 0.28 | 0.32 |
| EPS Actual | 0.31 | 0.27 | 0.31 | 0.33 |
| Difference | 0.02 | 0.05 | 0.03 | 0.01 |
| Surprise % | 8.38% | 21.56% | 10.47% | 4.44% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.35 | 0.26 | 1.31 | 1.29 |
| 7 Days Ago | 0.35 | 0.25 | 1.34 | 1.3 |
| 30 Days Ago | 0.34 | 0.25 | 1.28 | 1.27 |
| 60 Days Ago | 0.36 | 0.28 | 1.24 | 1.43 |
| 90 Days Ago | 0.36 | 0.28 | 1.24 | 1.43 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | -- | -- | 1 |
| Up Last 30 Days | 1 | -- | 2 | 1 |
| Down Last 7 Days | -- | 1 | -- | -- |
| Down Last 30 Days | 3 | 1 | 1 | 3 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| OPCH | 13.72% | -3.79% | 13.16% | -1.91% |
| S&P 500 | 8.58% | 11.41% | 13.97% | 13.43% |
Upgrades & Downgrades
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 1/10/2025 |
| Initiated | UBS: Neutral | 12/5/2024 |
| Downgrade | Goldman Sachs: Buy to Neutral | 11/5/2024 |
| Maintains | Truist Securities: Buy to Buy | 11/1/2024 |
| Maintains | Barrington Research: Outperform to Outperform | 10/31/2024 |
| Downgrade | Jefferies: Buy to Hold | 10/31/2024 |
Related Tickers
LFST LifeStance Health Group, Inc.
7.66
-0.91%
PNTG The Pennant Group, Inc.
26.10
+1.07%
HCSG Healthcare Services Group, Inc.
11.61
+1.22%
SGRY Surgery Partners, Inc.
20.88
+1.11%
AMED Amedisys, Inc.
92.03
+0.14%
GRDN Guardian Pharmacy Services, Inc.
20.89
+4.45%
ACHC Acadia Healthcare Company, Inc.
45.84
+2.04%
MD Pediatrix Medical Group, Inc.
13.11
+5.39%
BKDT Brookdale Senior Living Inc.
69.58
0.00%
ADUS Addus HomeCare Corporation
126.28
+0.75%